PROTOCOL NRG-BR002 – Temporarily Closed to Accrual
NRG-BR002, “A Phase IIR/III Trial of Standard of Care Therapy with or without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer,” will temporarily close to accrual at 5 PM ET today, Friday, September 13, as the trial has completed accrual to the phase IIR portion of the trial and is pending the full phase IIR primary endpoint analysis, per the protocol-specified statistical analysis plan.
The trial will be temporarily closed until the full number of events are reached for the phase IIR primary endpoint analysis and a decision is made as to whether or not the trial will continue to the phase III portion. A broadcast regarding reopening will be sent after that decision is made.
This message was sent to firstname.lastname@example.org by NRG-Broadcasts@NRGOncology.org
Four Penn Center
1600 JFK Blvd.
, Philadelphia, PA, 19103